Record NNP B-NP O
date NN I-NP O
: : O O
2080-03-13 CD O B-DATE
Ms. NNP B-NP O
Louise NNP I-NP B-PATIENT
Iles NNP I-NP I-PATIENT
is VBZ B-VP O
a DT B-NP O
70 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
female JJ I-NP O
patient NN I-NP O
of IN B-PP O
Dr. NNP B-NP O
Xue NNP I-NP B-DOCTOR
here RB I-NP O
today NN I-NP O
with IN B-PP O
first JJ B-NP O
visit NN I-NP O
with IN B-PP O
me PRP B-NP O
for IN B-PP O
several JJ B-NP O
issues NNS I-NP O
. . O O
Met NNP B-NP O
with IN B-PP O
PCP NNP B-NP O
in IN B-PP O
Feb NNP B-NP B-DATE
for IN B-PP O
multiple JJ B-NP O
issues NNS I-NP O
, , O O
DM NNP B-NP O
changed VBD B-VP O
from IN B-PP O
Actos NNP B-NP O
to TO B-PP O
Metformin NNP B-NP O
, , O O
referral NN B-NP O
to TO B-PP O
Internal NNP B-NP O
Medicine NNP I-NP O
; : O O
GERD/H-pylori NNP B-NP O
, , O O
( -LRB- B-NP O
on IN B-PP O
meds NNS B-NP O
, , O O
GI JJ B-VP O
consult VB I-VP O
) -RRB- B-NP O
HTN NN I-NP O
( -LRB- B-VP O
changed VBN I-VP O
from IN B-PP O
nitrates NNS B-NP O
to TO B-PP O
Lisinopril NNP B-NP O
) -RRB- I-NP O
cholesterol NN I-NP O
, , O O
HA NNP B-NP O
( -LRB- I-NP O
lab NN I-NP O
done VBN B-VP O
to TO B-VP O
r/o VB I-VP O
TA VBZ B-NP O
and CC O O
PMR NNP B-NP O
) -RRB- I-NP O
Hepatitis . O O
She PRP B-NP O
arrived VBD B-VP O
20 CD B-NP O
minutes NNS I-NP O
late RB B-ADVP O
for IN B-PP O
her PRP B-NP O
appointment NN B-NP O
Today NN B-NP O
states NNS I-NP O
: : O O
# # B-NP O
1 CD I-NP O
HA NNP I-NP O
HA NNP B-NP O
are VBP B-VP O
much JJ B-NP O
better-less JJ I-NP O
in IN B-PP O
frequency NN B-NP O
and CC I-NP O
duration NN I-NP O
and CC I-NP O
intensity NN I-NP O
, , O O
Left VBD B-VP O
area NN I-VP O
occipital/temporal JJ B-NP O
area NN I-NP O
ROS NNP B-NP O
denies VBZ B-VP O
any DT B-NP O
visual JJ I-NP O
problems-but NN I-NP O
does VBZ B-VP O
associate VB I-VP O
them PRP B-NP O
with IN B-PP O
stressful JJ B-NP O
times NNS I-NP O
# # B-NP O
2 CD I-NP O
DM . O O
Test VBG B-VP O
her PRP$ B-NP O
BG NNP I-NP O
once RB I-NP O
a DT B-NP O
week-reports NNS I-NP O
134 CD I-NP O
, , O O
today NN B-NP O
156-ate JJ B-ADJP O
at IN B-PP O
1 CD B-NP O
PM NNP I-NP O
rice NN I-NP O
Stopped NNP B-NP O
Actos-now NNP I-NP O
taking VBG B-VP O
Metformin NNP B-NP O
# # B-NP O
3 CD I-NP O
HTN . O O
taking VBG B-VP O
meds NNS B-NP O
as IN B-SBAR O
prescribed VBN O O
# # B-NP O
4 CD I-NP O
GERD NNP I-NP O
: : O O
completed VBN B-VP O
antibiotics-feeling JJ B-ADJP O
better RB O O
Medications NNS B-NP O
Amoxicillin NNP B-NP O
1000 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
500 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VBP B-VP O
2 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
14 CD I-NP O
days NNS B-PP O
# # B-NP O
56 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Aspirin NNP B-NP O
(ACETYLSALICYLIC NN I-NP O
ACID NNP I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
(81 VBD B-VP O
MG NNP B-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
# # O O
30 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Atenolol IN B-PP O
50 CD B-NP O
MG NN I-NP O
( -LRB- I-NP O
50MG JJ I-NP O
TABLET NN I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
# # O O
30 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Ergocalciferol NNP B-NP O
50000 CD I-NP O
UNITS NNP I-NP O
( -LRB- I-NP O
50000 CD I-NP O
UNIT NNP I-NP O
CAPSULE NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QWEEK NNP I-NP O
x NN I-NP O
42 CD B-NP O
days NNS I-NP O
# # I-NP O
6 CD I-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Lipitor NNP B-NP O
( -LRB- B-VP O
ATORVASTATIN NNP B-NP O
) -RRB- I-NP O
40 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
40 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QHS NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
# # O O
30 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Lisinopril NNP B-NP O
5 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
5 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
# # O O
30 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Metformin NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
500 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
30 CD I-NP O
days NNS I-NP O
#60 IN B-PP O
Tablet( NN B-NP O
s VBZ B-VP O
) -RRB- O O
Omeprazole NNP B-NP O
20 CD I-NP O
MG NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
DR NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP I-NP O
x NN I-NP O
14 CD B-NP O
days NNS I-NP O
# # B-PP O
28 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Problems NNS B-NP O
Diabetes NNP B-NP O
mellitus NN I-NP O
: : O O
dx NN B-NP O
late JJ I-NP O
2060s CD I-NP B-DATE
. . O O
No DT B-NP O
h/o NN I-NP O
macro NN I-NP O
or CC O O
microvascular JJ B-NP O
complications NNS I-NP O
. . O O
Hypertensive NNP B-NP O
disorder NN I-NP O
: : O O
dx NN B-NP O
2060s CD I-NP B-DATE
, , O O
was VBD B-VP O
taking VBG I-VP O
atenolol NN B-NP O
, , I-NP O
enalapril NN I-NP O
and CC I-NP O
isosorbide NN I-NP O
in IN B-PP O
UNITED NNP B-NP B-COUNTRY
KINGDOM NNP I-NP I-COUNTRY
Hypercholesterolemia NNP B-NP O
Obesity NN B-NP O
Osteoarthritis NNP B-NP O
: : O O
L NNP B-NP O
knee NN I-NP O
worst JJS I-NP O
spot NN I-NP O
Gastroesophageal NNP B-NP O
reflux NN I-NP O
disease NN I-NP O
: : O O
x LS B-NP O
years NNS I-NP O
, , O O
never RB B-ADVP O
had VBD B-VP O
EGD. NNP B-NP O
H. NNP I-NP O
pylori NN I-NP O
serology NN I-NP O
+ . O O
Helicobacter NNP B-NP O
pylori NN I-NP O
: : O O
serology NN B-NP O
positive JJ I-NP O
2068 CD I-NP B-DATE
and CC O O
re-check VB B-VP O
2/2080 CD B-NP B-DATE
, , O O
no DT B-NP O
Ag NNP I-NP O
done VBN B-VP O
. . B-NP O
Given VBN I-NP O
triple JJ I-NP O
therapy NN I-NP O
Rx NN I-NP O
by IN B-PP O
Internal NNP B-NP O
Medicine NNP I-NP O
Vitamin NN B-NP O
D NNP I-NP O
deficiency NN I-NP O
Hepatitis NNP B-NP O
B NNP I-NP O
antibody NN I-NP O
present RB B-ADVP O
: : O O
Had VBD B-VP O
HbsAg+ NNP B-NP O
and CC I-NP O
HbsAb+ NNP I-NP O
in IN B-PP O
2067 CD B-NP B-DATE
. . O O
LFTs NNP B-NP O
wnl VBD B-VP O
2067 CD B-NP B-DATE
and CC I-NP O
2080 CD I-NP B-DATE
. . O O
Allergies . O O
NKA . O O
O UH B-NP O
: : O O
Vital JJ B-NP O
Signs NNS I-NP O
BP NNP B-NP O
160/80 CD I-NP O
, , O O
Wt NNP B-NP O
203.8 CD I-NP O
lb NN I-NP O
Neck NNP B-NP O
: : O O
no DT B-NP O
bruits NNS I-NP O
Cardiac NNP B-NP O
: : O O
HR NNP B-NP O
76 CD I-NP O
RRR NN I-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
rubs NNS I-NP O
or CC O O
gallops NNS B-NP O
BP NNP B-NP O
both DT I-NP O
arms NNS I-NP O
162/8 VBD B-VP O
0 CD I-VP O
FINGER NNP B-NP O
BLOOD NNP I-NP O
GLUCOSE NNP I-NP O
156 CD I-NP O
two CD I-NP O
hours NNS I-NP O
PP NNP I-NP O
PAIN NNP B-NP O
LEVEL NNP I-NP O
(0-10 . O O
) -RRB- O O
0 CD O O
general JJ B-NP O
: : O O
overweight JJ B-NP O
female NN I-NP O
in IN B-PP O
NAD NN B-NP O
Pneumo NNP B-NP O
vaccine NN I-NP O
: : O O
. . B-NP O
5 CD I-NP O
ml NN I-NP O
given VBN B-VP O
in IN B-PP O
right JJ B-NP O
deltoid NN I-NP O
without IN B-PP O
difficulty NN B-NP O
Tdap NN B-NP O
. . O O
5 CD B-NP O
ml NN I-NP O
given VBN B-VP O
in IN B-PP O
left JJ B-NP O
deltoid NN I-NP O
without IN B-PP O
difficulty NN B-NP O
Results NNS B-NP O
02/15/2080 CD B-NP B-DATE
CHOL NNP I-NP O
187 CD I-NP O
[1] NN I-NP O
, , O O
TRIG NNP B-NP O
137 CD I-NP O
, , O O
HDL NNP B-NP O
37 CD I-NP O
, , O O
LDL NNP B-NP O
123 CD I-NP O
[2] NN I-NP O
, , O O
CHOL/HDL NNP B-NP O
5.1 CD I-NP O
[3][ VBD B-VP O
1 CD B-NP O
] SYM I-NP O
RESULT VBN I-NP O
COMMENT NNP I-NP O
: : O O
DESIRABLE NNP B-NP O
: : O O
&lt NN B-NP O
;200[2 CD I-NP O
] SYM O O
RESULT VBN B-NP O
COMMENT NNP I-NP O
: : O O
DESIRABLE NNP B-NP O
: : O O
&lt NN B-NP O
;130[3 CD I-NP O
] SYM O O
RESULT VBN B-NP O
COMMENT NNP I-NP O
: : O O
NORMAL NNP B-NP O
RISK NNP I-NP O
RATIO NNP I-NP O
: : O O
5.0 CD B-NP O
OR JJ I-NP O
LESS NNP I-NP O
02/15/2080 CD I-NP B-DATE
UCREAT NN I-NP O
1.39 CD B-NP O
, , O O
MALB NNP B-NP O
2.2 CD I-NP O
( -LRB- I-NP O
H) NNP I-NP O
, , O O
MALB/CRE NNP B-NP O
15.8 CD I-NP O
02/15/2080 CD I-NP B-DATE
WBC NNP B-NP O
4.2 CD I-NP O
( -LRB- I-NP O
L) NNP I-NP O
, , O O
RBC NNP B-NP O
4.21 CD I-NP O
, , O O
HGB NNP B-NP O
13.1 CD I-NP O
, , O O
HCT NNP B-NP O
39.9 CD I-NP O
, , O O
MCV NNP B-NP O
95 CD I-NP O
, , O O
MCH NNP B-NP O
31.0, CD I-NP O
MCHC NNP B-NP O
32.7 CD I-NP O
, , O O
PLT NNP B-NP O
225 CD I-NP O
02/15/2080 CD I-NP B-DATE
RDW NNP I-NP O
13.6 CD I-NP O
02/15/2080 CD I-NP B-DATE
METHOD NNP I-NP O
Auto NNP I-NP O
, , O O
%NEUT NNP B-NP O
40 CD I-NP O
, , O O
%LYMPH NNP B-NP O
52 CD I-NP O
( -LRB- I-NP O
H) NN I-NP O
, , O O
%MONO NNP B-NP O
6 CD I-NP O
, , O O
%EOS NNP B-NP O
1 CD I-NP O
, , O O
%BASO NNP B-NP O
1 CD I-NP O
02/15/2080 CD I-NP B-DATE
ESR NN I-NP O
21 CD B-NP O
( -LRB- I-NP O
H) NN I-NP O
02/15/2080 CD I-NP B-DATE
HBV-CAB NNP I-NP O
Positive NNP I-NP O
[1] NNP I-NP O
, , O O
HBV-SAB NNP B-NP O
Reactive NNP I-NP O
, , O O
HBV-SAG NNP B-NP O
Negative[ NNP I-NP O
1 CD I-NP O
] SYM I-NP O
RESULT VBN I-NP O
COMMENT NNP I-NP O
: : O O
Reference NN B-VP O
range NN B-NP O
: : O O
Negative( NNP B-NP O
NOTE)If NNP I-NP O
clinically RB B-ADVP O
indicated VBD B-VP O
, , O O
testing VBG B-VP O
for IN B-PP O
Hepatitis NNP B-NP O
B NNP I-NP O
Core NNP I-NP O
IgMAntibody NNP I-NP O
, , O O
Serum NNP B-NP O
, , O O
is VBZ B-VP O
necessary JJ B-ADJP O
to TO B-VP O
confirm VB I-VP O
an DT B-NP O
acute JJ I-NP O
or CC I-NP O
recentinfection.Performed JJ I-NP O
by IN B-PP O
HMH NNP B-NP B-ORGANIZATION
LABORATORIES NNP I-NP I-ORGANIZATION
, , O O
382 CD B-NP B-STREET
Farmington NNP I-NP I-STREET
Road NNP I-NP I-STREET
, , O O
Mount NNP B-NP B-CITY
Morris NNP I-NP I-CITY
, , O O
AK NNP B-NP B-STATE
34712 CD I-NP B-ZIP
RadiologyExam NNP I-NP O
Number NNP I-NP O
: : O O
13929520 CD B-NP B-MEDICALRECORD
Report NNP I-NP O
Status NNP I-NP O
: : O O
FinalType NNP B-NP O
: : O O
Chest NNP B-NP O
2 CD B-NP O
ViewsDate/Time NN I-NP O
: : O O
02/15/2080 CD B-NP B-DATE
09:04Exam NNP I-NP O
Code NNP I-NP O
: : O O
DNSW2 NNP B-NP B-MEDICALRECORD
Ordering NNP I-NP O
Provider NNP I-NP O
: : O O
Xue NNP B-NP I-DOCTOR
, , O I-DOCTOR
Laura NNP B-NP I-DOCTOR
M.D.REPORT NNP I-NP O
Frontal NNP I-NP O
and CC O O
lateral JJ B-NP O
views NNS I-NP O
of IN B-PP O
the DT B-NP O
chest NN I-NP O
. . B-NP O
COMPARISON NN I-NP O
: : O O
None NN B-NP O
FINDINGS NNS I-NP O
: : O O
Lines/tubes NNP B-NP O
: : O O
None NN B-NP O
. . O O
Lungs NNP B-NP O
: : O O
Bandlike NNP B-NP O
opacity NN I-NP O
consistent JJ I-NP O
with IN B-PP O
subsegmental JJ B-NP O
plate NN I-NP O
atelectasis NN I-NP O
at IN B-PP O
the DT B-NP O
left JJ I-NP O
lung NN I-NP O
base NN I-NP O
. . O O
Otherwise RB O O
clear JJ B-NP O
lungs NNS I-NP O
. . B-NP O
Pleura NN I-NP O
: : O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
pleural JJ I-NP O
effusion NN I-NP O
or CC I-NP O
pneumothorax NN I-NP O
. . O O
Heart '' O O
and CC O O
mediastinum NN B-NP O
: : O O
The DT B-NP O
heart NN I-NP O
and CC O O
the DT B-NP O
mediastinum NN I-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
Bones NNP O O
: : O O
The DT B-NP O
thoracic JJ I-NP O
skeleton NN I-NP O
is VBZ B-VP O
unremarkable JJ B-ADJP O
. . O O
IMPRESSION NNP O O
: : O O
Bandlike IN B-PP O
opacity NN B-NP O
consistent JJ I-NP O
with IN B-PP O
subsegmental JJ B-NP O
plate NN I-NP O
atelectasis NN I-NP O
at IN B-PP O
the DT B-NP O
left JJ I-NP O
lung NN I-NP O
base NN I-NP O
. . O O
Otherwise RB O O
clear JJ B-NP O
lungs NNS I-NP O
. . O O
RADIOLOGISTS NNS B-NP O
: : O O
SIGNATURES NNP B-NP O
: : O O
Querry NNP B-NP I-DOCTOR
, , O I-DOCTOR
Lucas NNP B-NP I-DOCTOR
Edwin NNP I-NP I-DOCTOR
MD NNP I-NP O
Querry NNP I-NP I-DOCTOR
, , O I-DOCTOR
Lucas NNP B-NP I-DOCTOR
Edwin NNP I-NP I-DOCTOR
MD NNP I-NP O
A: NNP B-NP O
# # I-NP O
1 CD I-NP O
HA NNP I-NP O
: : O O
better JJR B-NP O
sounds NNS I-NP O
more RBR B-ADVP O
like IN B-PP O
stress-reviewed JJ B-NP O
deep JJ I-NP O
breathing NN I-NP O
and CC O O
monitoring NN B-NP O
# # B-NP O
2 CD I-NP O
DM CD I-NP O
last JJ I-NP O
A1C JJ I-NP O
excellent JJ I-NP O
at IN B-PP O
5.9 CD B-NP O
% NN I-NP O
Eye NNP B-NP O
: : O O
seen VBN B-VP O
by IN B-PP O
Internal NNP B-NP O
Medicine-needs NNP I-NP O
repeat NN I-NP O
in IN B-PP O
1-2 JJ B-NP O
months NNS I-NP O
for IN B-PP O
inadequate JJ B-NP O
image NN I-NP O
of IN B-PP O
right JJ B-NP O
eye NN I-NP O
Feet NNP B-NP O
: : O O
address NN B-NP O
next JJ B-NP O
visit NN I-NP O
lipids NNS B-NP O
: : O O
LDL NNP B-NP O
123-but CC O O
HAV NNP B-NP O
+ NNP I-NP O
discussed VBD B-VP O
with IN B-PP O
PCP NNP B-NP O
before IN B-PP O
beginning VBG B-VP O
meds NNS B-NP O
ASA NNP B-NP O
81 CD I-NP O
mg NN I-NP O
daily RB B-SBAR O
Microalbumin NNP B-NP O
: : O O
2.2-just JJ B-NP O
began VBD B-VP O
Lisinopril NNP B-NP O
last JJ B-NP O
month NN I-NP O
# # B-NP O
3 CD I-NP O
HTN NN I-NP O
: : O O
above IN B-PP O
target NN B-NP O
today NN B-NP O
increase NN I-NP O
Lisinopril NNP I-NP O
to TO I-NP O
10 CD I-NP O
mg NN I-NP O
# # B-NP O
4 CD I-NP O
GERD-better NNP I-NP O
after IN B-PP O
treatment-schedule NN B-NP O
to TO B-VP O
see VB I-VP O
GI . O O
# # B-NP O
5 CD I-NP O
Low NNP I-NP O
WBC NNP I-NP O
3.4 CD I-NP O
in IN B-PP O
2/8 CD B-NP I-DATE
0 CD I-NP I-DATE
then RB O O
up IN B-NP O
to TO I-NP O
4.2 CD I-NP O
in IN B-PP O
feb NN B-NP B-DATE
# # B-NP O
6 CD I-NP O
Low NNP I-NP O
Vitamin NNP I-NP O
D-taking NNP I-NP O
replacement NN I-NP O
PPD NNP B-NP O
per IN B-PP O
patient NN B-NP O
+ NN I-NP O
in IN B-PP O
Mississippi NNP B-NP B-STATE
-did CC I-NP O
not RB I-NP O
plant NN O O
given VBN B-NP O
verbal JJ I-NP O
consent NN I-NP O
to TO B-VP O
administer VB I-VP O
Pneumo NNP B-NP O
vaccine NN I-NP O
and CC I-NP O
Tdap-declined JJ I-NP O
H NNP I-NP O
1 CD I-NP O
N NNP I-NP O
1 CD I-NP O
and CC O O
flu NN B-NP O
P NNP B-NP O
: : O O
PPD NNP B-NP O
, , I-NP O
tdap NN I-NP O
, , O O
H NNP B-NP O
1 CD I-NP O
N NNP B-NP O
1 CD I-NP O
, , O O
Pneumo NNP B-NP O
vaccine NN I-NP O
Lisinopril NNP B-NP O
10 CD I-NP O
mg NN I-NP O
po NN I-NP O
daily-recheck NN I-NP O
BMP NNP B-NP O
in IN B-PP O
6 CD B-NP O
weeks NNS I-NP O
screening VBG B-VP O
mammogram NN B-NP O
and CC I-NP O
Bone NN I-NP O
density NN I-NP O
Given VBN B-NP O
medication NN I-NP O
list NN I-NP O
to TO B-VP O
compare VB I-VP O
home NN B-NP O
bottles NNS I-NP O
RTC NNP B-NP O
: : O O
In IN B-NP O
2 CD I-NP O
weeks NNS I-NP O
for IN B-PP O
BP NNP B-NP O
check VBP B-VP O
April NNP B-NP B-DATE
with IN B-PP O
PCP NNP B-NP O
and CC O O
two CD B-NP O
months NNS I-NP O
with IN B-PP O
me PRP B-NP O
for IN B-PP O
shared VBN B-NP O
care NN I-NP O
RCHM NNP B-NP O
: : O O
PE NN B-NP O
( -LRB- I-NP O
2/8 CD I-NP I-DATE
0 CD I-NP I-DATE
) -RRB- I-NP O
PAP NNP I-NP O
none NN I-NP O
in IN B-PP O
LMR NNP B-NP O
needs VBZ B-VP O
: : O O
immunizations NNS B-NP O
: : O O
pneumo JJ B-NP O
vaccine NN I-NP O
and CC O O
Tdap NN B-NP O
Visit NNP B-NP O
lasted VBD B-VP O
45 CD B-NP O
minutes NNS I-NP O
&gt RB B-ADVP O
;50 CD B-NP O
% NN I-NP O
of IN B-PP O
time NN B-NP O
spent VBN B-VP O
on IN B-PP O
medications NNS B-NP O
, , O O
BG NNP B-NP O
, , O O
vaccine NN B-NP O
and CC B-PP O
up IN B-PP O
coming VBG B-NP O
appointment NN I-NP O
Entire NNP B-NP O
visit NN I-NP O
done VBN B-VP O
with IN B-PP O
professional JJ B-NP O
staff NN I-NP O
interpreter NN I-NP O
. . O O
Medication NNP B-NP O
and CC I-NP O
allergies NNS I-NP O
reviewed VBN B-VP O
and CC I-VP O
reconciled VBN I-VP O
with IN B-PP O
patient NN B-NP O
